艾瑞製藥ARRY
那斯達克 · USD
6.50
-0.14
(-2.11%)
收盤 08/01 03:59 (UTC+8)
盤後
6.61
+0.11
(+1.69%)
08/01 03:59 (UTC+8)
艾瑞製藥ARRY
6.50
-0.14
(-2.11%)
財務數據
損益表
- 4.02
- 3.77
- 5.08
- 3.50
- 3.42
- 1.53
- 2.56
- 2.31
- 2.75
- 3.02
- -21.93
- -6.29
- 34.76
- -30.98
- -2.52
- -55.09
- 66.73
- -9.52
- 18.94
- 9.86
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 302,363 | 275,232 | 231,406 | 255,766 | 153,403 | 341,615 | 350,438 | 507,725 | 376,773 | 402,071 |
營業成本 | 225,935 | 196,913 | 153,091 | 169,813 | 98,313 | 257,386 | 263,058 | 354,044 | 275,594 | 310,633 |
營業毛利 | 76,428 | 78,319 | 78,315 | 85,953 | 55,090 | 84,229 | 87,380 | 153,681 | 101,179 | 91,438 |
營業費用 | 49,144 | - | 210,990 | 46,351 | 46,676 | 54,009 | 47,175 | 57,440 | 53,721 | 75,089 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 43,795 | 46,059 | 40,110 | 37,474 | 37,049 | 44,442 | 37,622 | 40,955 | 39,480 | 39,187 |
非經常性項目費用 | - | 165,904 | 162,000 | - | - | - | - | - | - | - |
其他營業費用 | 5,349 | 8,702 | 8,880 | 8,877 | 9,627 | 9,567 | 9,553 | 16,485 | 14,241 | 35,902 |
營業利益 | 27,284 | -142,346 | -132,675 | 39,602 | 8,414 | 30,220 | 40,205 | 96,241 | 47,458 | 16,349 |
其他收入及費用 | 4,031 | 1,304 | 3,435 | 2,520 | 3,995 | 992 | 2,046 | -2,102 | -1,950 | 1,900 |
利息費用 | 8,035 | 9,007 | 8,264 | 8,614 | 8,940 | 8,857 | 13,064 | 8,878 | 9,500 | 9,701 |
稅前純益 | 23,280 | -150,049 | -137,504 | 33,508 | 3,469 | 22,355 | 29,187 | 85,261 | 36,008 | 8,548 |
所得稅 | 6,534 | -23,146 | 3,850 | 7,810 | 1,304 | 3,013 | 9,833 | 23,956 | 9,876 | 13,799 |
稅後純益 | 16,746 | -126,903 | -141,354 | 25,698 | 2,165 | 19,342 | 19,354 | 61,305 | 26,132 | -5,251 |
基本每股稅後盈餘(元) | 0.02 | -0.93 | -1.02 | 0.08 | -0.07 | 0.04 | 0.07 | 0.34 | 0.11 | -0.11 |
稀釋每股稅後盈餘(元) | 0.02 | -0.93 | -1.02 | 0.07 | -0.07 | 0.04 | 0.06 | 0.35 | 0.11 | -0.11 |
基本平均股數(千股) | 152076.00 | 151944.00 | 151923.00 | 151797.00 | 151351.00 | 151175.00 | 151068.00 | 150919.00 | 150607.00 | 150463.00 |
稀釋平均股數(千股) | 152783.00 | 151944.00 | 151923.00 | 152207.00 | 151351.00 | 152110.00 | 152323.00 | 152129.00 | 151795.00 | 150463.00 |
還原基本每股稅後盈餘(元) | 0.02 | -0.93 | -1.02 | 0.08 | -0.07 | 0.04 | 0.07 | 0.34 | 0.11 | -0.11 |
還原稀釋每股稅後盈餘(元) | 0.02 | -0.93 | -1.02 | 0.07 | -0.07 | 0.04 | 0.06 | 0.35 | 0.11 | -0.11 |
還原基本平均股數(千股) | 152,076 | 151,944 | 151,923 | 151,797 | 151,351 | 151,175 | 151,068 | 150,919 | 150,607 | 150,463 |
還原稀釋平均股數(千股) | 152,783 | 151,944 | 151,923 | 152,207 | 151,351 | 152,110 | 152,323 | 152,129 | 151,795 | 150,463 |
EBITDA(千元) | 42,392 | -126,761 | -114,491 | 56,641 | 27,726 | 46,249 | 59,920 | 109,470 | 62,867 | 46,205 |